Nonprofit drug developer in uphill battle against Trump administration contraception rule change


Medicines360 is pushing its low-cost IUD into African nations while its U.S. market faces pressure from a potential change in rules for a federal program.

Previous AbbVie Biotherapeutics director leads team against cancer
Next Developer eyes 168 apartment units in northern Loveland